About CodonRX®
Our Mission
At CodonRX®, we believe that breakthroughs in science should be accessible to everyone. Our mission is to bring innovative, research-driven probiotics to the market—empowering individuals to take control of their gut health and overall well-being.
Our Story
CodonRX® was founded with the goal of making high-quality, science-backed health products more affordable and accessible. Our team of experts at NC State developed our proprietary AI (Anti-Inflammatory) formulation to provide targeted relief for chronic digestive symptoms, including diarrhea, bloating, gas, abdominal pain, and constipation.
What Makes Us Unique
- Patented Formula: Our exclusive AI formulation is protected by patents worldwide, ensuring you receive the most advanced probiotic solution available.
- Scientifically Advanced: CodonRX® products are developed using cutting-edge research and technology, providing effective relief for IBS symptoms.
- Quality Assurance: Manufactured in the USA under stringent conditions, our products are independently tested for potency and purity. CodonRX® probiotics are vegan and allergen-free, containing no gluten, dairy, eggs, soy, shellfish, tree nuts, coconut, peanuts, fish, wheat, sesame seeds, or pesticides.
Our Values
- Innovation: We continuously strive to develop new and improved health solutions.
- Accessibility: We aim to make our products affordable and accessible to everyone.
- Integrity: We uphold the highest standards of quality and transparency in everything we do.
Meet Our Team
Our dedicated team of scientists, researchers, and health experts work tirelessly to bring you the best in gut health solutions. Learn more about the individuals behind CodonRX® and their commitment to improving your health.
Kevin White, PhD - Founder and Chairman
Our founder, Dr. Kevin White, has had a career spanning top research institutions—including Stanford, Yale, and the University of Chicago—and in industry as President and Chief Science Officer of Tempus AI, a leader in AI-driven precision medicine, which debuted on Nasdaq in June 2024. Dr. White has pioneered innovative approaches in precision medicine, bringing cutting-edge scientific advancements from the lab to real-world applications.
Andrew Lim, PhD - Chief Operations Officer
Our COO, Dr. Andrew Lim, brings global leadership experience across healthcare, technology and AI, having held executive roles at Genome.One, Garvan Institute and DNAnexus. He’s led commercial operations and strategy, business development, and digital innovation initiatives, with prior roles at Seagate Technology, Telstra, and the Boston Consulting Group. Dr. Lim holds a Ph.D. from UC Berkeley and a B.Sc. (Hons) from the University of Sydney.
Lauren Kan, MSc - Head of Product
Our Head of Product, Lauren Kan, brings over a decade of experience leading data- driven healthcare initiatives. She previously managed precision oncology reporting and product development at Tempus AI and led the informatics efforts for the Chicago Department of Public Health’s COVID-19 response. With a background in bioinformatics and operations, Lauren specializes in building practical, cross-functional solutions that improve patient outcomes and healthcare delivery.
Rodolphe Barrangou, PhD - Chief Scientific Advisor
Dr. Rodolphe Barrangou, Chairman of the CodonRX Scientific Advisory Board, is a global leader in microbiome and CRISPR research. He’s the inventor on the first CRISPR patent, a founder of Intellia Therapeutics (Nasdaq: NTLA), and Chairman of Caribou Biosciences. A former probiotics engineer at DuPont, he is now a Distinguished Professor at NC State, helping shape CodonRX’s scientific direction.
Join Us on Our Journey
Take control of your health with CodonRX® probiotics. Sign up for early access to our app and stay updated on the latest advancements in gut health.